Should you buy ATH.AX stock?
Last updated:
Based on market data through , StockInvest.us rates Alterity Therapeutics Limited (ATH.AX) as a Sell Candidate with a technical score of -3.57 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Down 3.57%
- 3-month trend forecast Down 83.03%
- High gross margin of 96.8%
- Lower volatility than the market (beta -0.04)
- Low bankruptcy risk (Altman Z-Score: 18.41)
Alterity Therapeutics Limited stock price up 0.93% on Tuesday
(Market data through Aug 11, 2026)
The Alterity Therapeutics Limited stock price gained 0.93% on the last trading day (Tuesday, 11th Aug 2026), rising from A$0.535 to A$0.540. During the last trading day the stock fluctuated 1.87% from a day low at A$0.535 to a day high of A$0.545. The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. Volume fell on the last day by -34 thousand shares and in total, 14 thousand shares were bought and sold for approximately A$7.38 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at A$5.25 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.
ATH.AX Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, June 12, 2026, and so far it has risen 9.09%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Alterity Therapeutics Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at A$0.546 and A$0.582. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Alterity Therapeutics Limited stock
Alterity Therapeutics Limited finds support from accumulated volume at A$0.525 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved A$0.0100 between high and low, or 1.87%. For the last week the stock has had daily average volatility of 4.78%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ATH.AX) For The Upcoming Trading Day Of Wednesday 12th
For the upcoming trading day on Wednesday, 12th we expect Alterity Therapeutics Limited to open at A$0.540, and during the day (based on 14 day Average True Range), to move between A$0.430 and A$0.650, which gives a possible trading interval of +/-A$0.221 (+/-51.35%) up or down from last closing price. If Alterity Therapeutics Limited takes out the full calculated possible swing range there will be an estimated 51.35% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at A$0.525 (2.78%) than the resistance at A$0.600 (11.11%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Alterity Therapeutics Limited stock A Buy?
Alterity Therapeutics Limited holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-3.571
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 12, 2026 - A$0.540 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ATH.AX Performance
Trading levels for ATH.AX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.550 | 1.85% |
| R2 | 0.546 | 1.14% |
| R1 | 0.544 | 0.707% |
| Price | 0.540 | |
| S1 | 0.536 | -0.707% |
| S2 | 0.534 | -1.14% |
| S3 | 0.530 | -1.85% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.660 | 22.22% |
| R2 | 0.650 | 20.37% |
| R1 | 0.600 | 11.11% |
| Price | 0.540 | |
| S1 | 0.525 | -2.78% |
| S2 | 0.510 | -5.56% |
| S3 | 0.450 | -16.67% |
FAQ
Click here for our free guide on how to buy Alterity Therapeutics Limited Stock.
Buy ATH